Acute myeloid leukemia screening

Acute myeloid leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Acute myeloid leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardigram
Chest X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acute myeloid leukemia screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acute myeloid leukemia screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acute myeloid leukemia screening
CDC on Acute myeloid leukemia screening
Acute myeloid leukemia screening in the news
Blogs on Acute myeloid leukemia screening
Directions to Hospitals Treating Acute myeloid leukemia
Risk calculators and risk factors for Acute myeloid leukemia screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Shyam Patel [2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]

Overview

There are currently no guidelines for screening for acute myeloid leukemia. Monitoring of the complete blood count is done routinely.

Screening

There are currently no guidelines for screening for acute myeloid leukemia. Routine monitoring of complete blood count (CBC) once yearly is sufficient for screening for hematologic diseases in general.